Biosynex SA 13D and 13G filings for Chembio Diagnostics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-01 09:21 am Purchase | 2023-04-27 | 13D | Chembio Diagnostics, Inc. CEMI | Biosynex SA | 37,059,993 100.000% | 37,059,993 (New Position) | Filing |